My understanding is that ABUS are going to cut costs, sell off their remaining assets (HEP B program, if I recall) & exclusively be a shell w/ a claim on the litigation of intellectual property claim against MRNA & PFE. Worth reading the last few K's.
My understanding is that ABUS are going to cut costs, sell off their remaining assets (HEP B program, if I recall) & exclusively be a shell w/ a claim on the litigation of intellectual property claim against MRNA & PFE. Worth reading the last few K's.
My understanding is that ABUS are going to cut costs, sell off their remaining assets (HEP B program, if I recall) & exclusively be a shell w/ a claim on the litigation of intellectual property claim against MRNA & PFE. Worth reading the last few K's.